Table 2.
Simplified scheme for economical 4-site ID rabies postexposure vaccination
| Number of ID sites injected | ||||||
|---|---|---|---|---|---|---|
| Day 0 | Day 3 | Day 7 | Day 28 | Visits | Total vaccine | |
| Primary Postexposure Regimens | ||||||
| 2-visit 4-site PEP* | 4† | – | 2 | – | 2 | 1.5 vials, same for all vaccines, 2 vials if no sharing |
| 2-visit 4-site PEP with 3rd dose for immunosuppressed patients, optional if healthy* | 4† | – | 2 | 1 | 3 | < 2 vials, same for all vaccines, 3 vials if no sharing |
| Postexposure booster regimen for those previously immunized | ||||||
| Single day, 4-site | 4‡ | – | – | – | 1 | 0.5–1 vial |
ID = intradermal; PEP = postexposure rabies prophylaxis.
* ID doses are 0.1 mL/site for 0.5 mL/vial vaccine (Purified Vero cell Rabies Vaccine, Verorab; Sanofi, Lyon, France) or 0.2 mL/site for 1.0 mL/vial vaccine (Purified Chick Embryo Cell Vaccine, Rabipur/RabAvert; GSK, Marburg, Germany).
† Use whole vial.
‡ Preferably using a whole vial especially if previously vaccinated several years before, but half vial can be used with 1-mL vaccines.